Status:
RECRUITING
Individualized Alpha Neurofeedback for ADHD
Lead Sponsor:
The University of Hong Kong
Conditions:
ADHD
Eligibility:
All Genders
5-13 years
Phase:
NA
Brief Summary
Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent neurodevelopmental disorders, characterised by inattention, hyperactivity, and impulsivity. Although pharmacotherapy is con...
Detailed Description
120 ADHD children will be invited to join the RCT neurofeedback training. They will be randomly assigned to one of two groups (neurofeedback group, sham feedback group, ). For the neurofeedback group ...
Eligibility Criteria
Inclusion
- Fulfilment of the DSM-IV-TR criteria for ADHD
- No intention to use new medication/change dosage/join new non-pharmacological treatment program during the intervention period.
Exclusion
- Diagnosis of cerebral palsy/ history of structural brain abnormalities on CT/ MRI;
- full-scale IQ score (FSIQ) \< 70;
- A history of seizure or prior electroencephalogram abnormalities related to epilepsy.
- Having comorbid psychiatric disorders, including schizophrenia or schizoaffective disorder, bipolar disorder, borderline personality disorder, epilepsy, or traumatic brain injury; current substance abuse or dependence
- Planned other behavioural/durg treatment during the intervention period
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06142786
Start Date
June 1 2024
End Date
December 25 2026
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Li Ka Shing Faculty of Medicine
Hong Kong, Hong Kong, Hong Kong, 0000